Cedar Woods Hits Record Profit, But Insiders Forfeit Bonuses—Smart Money Sells

The numbers on paper are spectacular. Cedar Woods just reported a record net profit after tax of $39.6 million for the first half of FY26, a 164% surge from the prior year. Revenue exploded 40%, and the company is guiding for another 30% to 35% profit growth for the full year. This is the kind of headline that fuels a rally.

Yet the stock has been doing the opposite. Over the past week, it has fallen 10.4% to close at $7.13. That's a stark divergence between the operational story and what the market is pricing in. The smart money, it seems, is looking past the profit numbers and focusing on what insiders are doing with their own skin in the game.

A clear red flag is the recent lapse of performance rights. The company announced that 38,547 performance rights lapsed due to unmet vesting conditions as of December 31, 2025. That's not just a minor administrative detail; it's a formal signal that internal targets were missed. When the board decides that executives didn't earn their bonuses, it raises questions about whether the lofty guidance is fully aligned with reality.

This sets up a classic tension. The company is delivering record profits, but the internal compensation structure is being reset because targets weren't hit. For a stock to sustain a rally, you need alignment between the company's story and the interests of those who know it best. When the CEO and the board are effectively saying "we didn't hit our goals," while simultaneously guiding for massive profit growth, it creates a credibility gap. The whale wallet is taking profits on a story that insiders themselves are questioning.

Skin in the Game: What Executives Are Actually Doing

The CEO's own financial stake tells the real story. Nathan Blackburne, who has led the company for over eight years, holds a direct ownership stake of 0.45% of the company's shares, worth roughly A$2.77 million. His total annual compensation is a substantial A$1.38 million, with a significant portion tied to performance bonuses. Yet the latest data shows his skin in the game wasn't fully earned.

The board recently decided that executives did not hit their targets. As of December 31, 2025, 38,547 performance rights lapsed due to unmet vesting conditions. That means the CEO's own bonus for that period was not paid out. When the compensation committee formally says an executive didn't earn their payout, it's a direct signal that internal performance goals were missed. This creates a clear credibility gap: the company is guiding for massive profit growth, but the CEO's own bonus was forfeited because targets weren't hit.

This is the kind of misalignment that worries smart money. The CEO is paid handsomely to hit goals, but when those goals are missed, the board doesn't force him to pay back his salary. Instead, the penalty is a loss of future stock-based compensation. That's a weak incentive to ensure the guidance is realistic. The whale wallet is taking profits while the CEO's own performance-based pay was left on the table.

There is a positive signal from the top, but it's small and doesn't change the narrative. The Founder & Chairman recently purchased A$71,000 worth of stock. That's a vote of confidence, but it's a minor addition to a much larger ownership base and doesn't offset the CEO's actions. In the end, the smart money looks at the filings, not the press releases. When the CEO's bonus is forfeited and his stock sales are likely in motion, the alignment of interest is clearly broken.

Institutional Accumulation: The Smart Money's Move

The setup here is a classic puzzle. On paper, the case for Cedar Woods looks strong. The company is guiding for another 30% to 35% profit growth for the full year, backed by a record half-year profit and a powerful 40% revenue surge. It has a fortress balance sheet, with over $189 million in cash and net debt slashed by 40%. The market cap sits at A$727.4 million, and the sole analyst price target of A$10.00 implies significant upside from current levels. This is the kind of financial strength that should attract institutional accumulation.

Yet, the smart money's move is not yet clear. While the company's own filings show insiders questioning the guidance with forfeited bonuses, we lack the 13F filings that would show what larger, more sophisticated investors are actually doing. The absence of this data is telling. In a stock with a clear catalyst-a massive guidance upgrade and a strong cash position-smart money typically moves early. Their absence suggests either caution or a wait-and-see stance.

The company's own actions provide a clue. By providing detailed guidance for FY27 and highlighting a $748 million pre-sales pipeline that will settle primarily in the following year, management is signaling a long runway. This forward visibility is a key attraction for patient capital. However, the recent insider selling and the lapse of performance rights create a credibility gap that even strong fundamentals may not immediately overcome. For now, the institutional whale wallet is silent, watching the CEO's skin in the game and the stock's weak price action. Until we see those 13F filings show accumulation, the smart money's verdict remains pending.

Catalysts and Risks: What to Watch Next

The thesis here is clear: the lapse of performance rights is a red flag if it signals the company is struggling to meet internal targets, despite the strong headline profit. The near-term catalysts will test that thesis directly. The smart money is watching for two key signals: insider actions and execution against the guidance.

First, watch for any significant insider buying or selling in the coming months, especially from the CEO or CFO. The CEO's own performance-based pay was forfeited, and his direct ownership stake is worth a few million dollars. If he is selling shares now, it would be a powerful signal that his skin in the game is being shed. Conversely, any meaningful insider accumulation would be a bullish counter-narrative, suggesting confidence that the guidance is achievable. The recent purchase by the Founder & Chairman of A$71,000 is a small, positive signal, but it's dwarfed by the CEO's potential position. Until we see larger, more consistent moves from the top, the alignment of interest remains broken.

Second, monitor execution against the FY26 guidance and progress on key projects. The company is guiding for another 30% to 35% profit growth for the full year, a massive step-up from the already-record half-year. The path to that target will be scrutinized. Look for updates on the over $748 million pre-sales pipeline, which is expected to settle primarily in FY27. This is a key metric; if settlements lag, it could pressure near-term revenue and cash flow. Also watch for any changes to the gross margin of 31%, which drove the profit surge. Maintaining that margin while scaling is the real test.

The lapse of 38,547 performance rights is the central red flag. It means the board formally judged that internal targets were missed. If the company can now deliver on its own guidance, it will contradict that earlier assessment and restore credibility. If it struggles, the lapse becomes a prescient warning. The coming quarters will show whether the smart money's caution was justified or if the record profit is just the start of a longer growth story.